Yuko Tagata

Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer’s disease: a prospective, open-label pilot study

Tohru Ohnuma, Aiko Toda, Ayako Kimoto et al. · Clinical Interventions in Aging · 2016 · 80 citations · Full text

Medicine, Geriatric Medicine, Neurology +16

Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer’s disease patients

Takayuki Kondo, Norikazu Hara, Satoshi Koyama et al. · Nature Aging · 2022 · 27 citations

Life Sciences, Neurobiology, Neuroscience +17

Polymorphisms in the aldehyde dehydrogenase 2 and dopamine β hydroxylase genes are not associated with Alzheimer’s disease

Miwa Komatsu, Nobuto Shibata, Tohru Ohnuma et al. · Journal of Neural Transmission · 2013 · 19 citations

Life Sciences, Genetics, Molecular Genetics +14

Polygenic effects on the risk of Alzheimer’s disease in the Japanese population

Masataka Kikuchi, Akinori Miyashita, Norikazu Hara et al. · Alzheimer s Research & Therapy · 2024 · 19 citations · Full text

Life Sciences, Biostatistics, Genetics +17

Changes in <scp>M</scp>ini‐<scp>M</scp>ental <scp>S</scp>tate <scp>E</scp>xamination score in <scp>A</scp>lzheimer's disease patients after stopping habitual drinking

Aiko Toda, Yuko Tagata, Tomoko Nakada et al. · Psychogeriatrics · 2013 · 11 citations · Full text

Medicine, Neurology, Psychiatry +12